JPWO2020249977A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020249977A5 JPWO2020249977A5 JP2021571931A JP2021571931A JPWO2020249977A5 JP WO2020249977 A5 JPWO2020249977 A5 JP WO2020249977A5 JP 2021571931 A JP2021571931 A JP 2021571931A JP 2021571931 A JP2021571931 A JP 2021571931A JP WO2020249977 A5 JPWO2020249977 A5 JP WO2020249977A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- dose
- demand
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023131860A JP2023166406A (ja) | 2019-06-14 | 2023-08-14 | 遺伝性血管性浮腫の治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962861725P | 2019-06-14 | 2019-06-14 | |
| US62/861,725 | 2019-06-14 | ||
| GB1910116.1 | 2019-07-15 | ||
| GBGB1910116.1A GB201910116D0 (en) | 2019-07-15 | 2019-07-15 | Treatments of hereditary angioedema |
| PCT/GB2020/051439 WO2020249977A1 (en) | 2019-06-14 | 2020-06-15 | Treatments of hereditary angioedema |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023131860A Division JP2023166406A (ja) | 2019-06-14 | 2023-08-14 | 遺伝性血管性浮腫の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022536287A JP2022536287A (ja) | 2022-08-15 |
| JPWO2020249977A5 true JPWO2020249977A5 (zh) | 2023-01-23 |
| JP7356518B2 JP7356518B2 (ja) | 2023-10-04 |
Family
ID=67700145
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571931A Active JP7356518B2 (ja) | 2019-06-14 | 2020-06-15 | 遺伝性血管性浮腫の治療 |
| JP2023131860A Pending JP2023166406A (ja) | 2019-06-14 | 2023-08-14 | 遺伝性血管性浮腫の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023131860A Pending JP2023166406A (ja) | 2019-06-14 | 2023-08-14 | 遺伝性血管性浮腫の治療 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20220218680A1 (zh) |
| EP (2) | EP3982960B1 (zh) |
| JP (2) | JP7356518B2 (zh) |
| KR (1) | KR20220024220A (zh) |
| CN (1) | CN114126612A (zh) |
| AR (1) | AR119158A1 (zh) |
| AU (1) | AU2020293614B2 (zh) |
| BR (1) | BR112021024664A2 (zh) |
| CA (1) | CA3142218A1 (zh) |
| CL (2) | CL2021003244A1 (zh) |
| DK (1) | DK3982960T3 (zh) |
| EA (1) | EA202193019A1 (zh) |
| ES (1) | ES2956471T3 (zh) |
| FI (1) | FI3982960T3 (zh) |
| GB (1) | GB201910116D0 (zh) |
| HR (1) | HRP20230696T1 (zh) |
| HU (1) | HUE063163T2 (zh) |
| IL (1) | IL288615A (zh) |
| LT (1) | LT3982960T (zh) |
| MA (1) | MA56187B1 (zh) |
| MD (1) | MD3982960T2 (zh) |
| MX (1) | MX2021014557A (zh) |
| PL (1) | PL3982960T3 (zh) |
| PT (1) | PT3982960T (zh) |
| RS (1) | RS64412B1 (zh) |
| SG (1) | SG11202113304YA (zh) |
| SI (1) | SI3982960T1 (zh) |
| TW (1) | TW202112370A (zh) |
| WO (1) | WO2020249977A1 (zh) |
| ZA (1) | ZA202110685B (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| EP4010333A1 (en) | 2019-08-09 | 2022-06-15 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
| WO2022084693A1 (en) * | 2020-10-23 | 2022-04-28 | Kalvista Pharmaceuticals Limited | Treatments of angioedema |
| WO2022172006A1 (en) | 2021-02-09 | 2022-08-18 | Kalvista Pharmaceuticals Limited | Treatments of hereditary angioedema |
| LT4288036T (lt) | 2022-04-27 | 2024-09-25 | Kalvista Pharmaceuticals Limited | Farmacinės plazmos kalikreino inhibitoriaus formos |
| CN116003386B (zh) * | 2022-11-20 | 2024-03-26 | 药康众拓(北京)医药科技有限公司 | 一种氘代n-苄基吡啶酮吡唑甲酰胺类化合物、药物组合物和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| GB9019558D0 (en) | 1990-09-07 | 1990-10-24 | Szelke Michael | Enzyme inhibitors |
| SE9301911D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptide derivatives |
| US5589467A (en) | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| GB0205527D0 (en) | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
| US7429604B2 (en) | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
| EP2051707B1 (en) | 2006-07-31 | 2013-07-17 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
| DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
| JP2013121919A (ja) | 2010-03-25 | 2013-06-20 | Astellas Pharma Inc | 血漿カリクレイン阻害剤 |
| EP2590945B1 (en) | 2010-07-07 | 2014-04-30 | The Medicines Company (Leipzig) GmbH | Serine protease inhibitors |
| EP2595986A2 (en) | 2010-07-14 | 2013-05-29 | Addex Pharma SA | Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| GB2494851A (en) | 2011-07-07 | 2013-03-27 | Kalvista Pharmaceuticals Ltd | Plasma kallikrein inhibitors |
| GB201300304D0 (en) | 2013-01-08 | 2013-02-20 | Kalvista Pharmaceuticals Ltd | Benzylamine derivatives |
| CA2912285C (en) | 2013-05-23 | 2021-07-13 | Kalvista Pharmaceuticals Limited | Fused 6,5 or 6,6-heteroaromatic bicyclic amide derivatives and pharmaceutical compositions thereof useful as plasma kallikrein inhibitor |
| EP2886107A1 (en) * | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Oral formulations of pyrrolydine derivatives |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| GB201721515D0 (en) | 2017-12-21 | 2018-02-07 | Kalvista Pharmaceuticals Ltd | Dosage forms comprising a plasma kallikrein inhibtor |
-
2019
- 2019-07-15 GB GBGB1910116.1A patent/GB201910116D0/en not_active Ceased
-
2020
- 2020-06-15 EP EP20734283.3A patent/EP3982960B1/en active Active
- 2020-06-15 MD MDE20220440T patent/MD3982960T2/ro unknown
- 2020-06-15 TW TW109120108A patent/TW202112370A/zh unknown
- 2020-06-15 HU HUE20734283A patent/HUE063163T2/hu unknown
- 2020-06-15 CN CN202080043365.6A patent/CN114126612A/zh active Pending
- 2020-06-15 US US17/617,439 patent/US20220218680A1/en active Pending
- 2020-06-15 SG SG11202113304YA patent/SG11202113304YA/en unknown
- 2020-06-15 EP EP23181261.1A patent/EP4282474A3/en active Pending
- 2020-06-15 RS RS20230620A patent/RS64412B1/sr unknown
- 2020-06-15 PT PT207342833T patent/PT3982960T/pt unknown
- 2020-06-15 HR HRP20230696TT patent/HRP20230696T1/hr unknown
- 2020-06-15 MA MA56187A patent/MA56187B1/fr unknown
- 2020-06-15 PL PL20734283.3T patent/PL3982960T3/pl unknown
- 2020-06-15 WO PCT/GB2020/051439 patent/WO2020249977A1/en active Application Filing
- 2020-06-15 JP JP2021571931A patent/JP7356518B2/ja active Active
- 2020-06-15 CA CA3142218A patent/CA3142218A1/en active Pending
- 2020-06-15 KR KR1020217043374A patent/KR20220024220A/ko active Search and Examination
- 2020-06-15 SI SI202030247T patent/SI3982960T1/sl unknown
- 2020-06-15 DK DK20734283.3T patent/DK3982960T3/da active
- 2020-06-15 BR BR112021024664A patent/BR112021024664A2/pt unknown
- 2020-06-15 MX MX2021014557A patent/MX2021014557A/es unknown
- 2020-06-15 LT LTEPPCT/GB2020/051439T patent/LT3982960T/lt unknown
- 2020-06-15 AU AU2020293614A patent/AU2020293614B2/en active Active
- 2020-06-15 ES ES20734283T patent/ES2956471T3/es active Active
- 2020-06-15 FI FIEP20734283.3T patent/FI3982960T3/fi active
- 2020-06-15 EA EA202193019A patent/EA202193019A1/ru unknown
- 2020-06-16 AR ARP200101681A patent/AR119158A1/es unknown
-
2021
- 2021-12-02 IL IL288615A patent/IL288615A/en unknown
- 2021-12-06 CL CL2021003244A patent/CL2021003244A1/es unknown
- 2021-12-20 ZA ZA2021/10685A patent/ZA202110685B/en unknown
-
2023
- 2023-03-06 CL CL2023000639A patent/CL2023000639A1/es unknown
- 2023-08-14 JP JP2023131860A patent/JP2023166406A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3982960T3 (fi) | Perinnöllisen angioödeeman hoitoja | |
| CA2683779C (en) | Tapentadol for treating pain due to osteoarthritis | |
| JP2002524498A (ja) | 機能性及び／又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用 | |
| EP1704860B1 (en) | Benzamidine derivatives for treatment and prevention of mucositis | |
| JPH0920659A (ja) | 炎症性腹部疾患のためのカッパ−アヘン製剤作働薬 | |
| CA3183560A1 (en) | Compositions and methods for treating alzheimer's disease and parkinson's disease | |
| Ventafridda et al. | Non-steroidal antiinflammatory drugs as the first step in cancer pain therapy: double-blind, within-patient study comparing nine drugs | |
| JPWO2020249977A5 (zh) | ||
| CN1744897A (zh) | 结合有泰妥拉唑与消炎剂的药物组合物 | |
| EP2723448B1 (en) | Compositions for the treatment of chronic fatigue | |
| JPWO2020249979A5 (zh) | ||
| WO2013191724A1 (en) | Compositions and methods for treatment of neuropsychological deficits | |
| AU2011283462B9 (en) | Therapeutic agent or prophylactic agent for neuropathic pain | |
| TW202102209A (zh) | 低劑量三重組合調配物 | |
| CN115317478A (zh) | 沙库巴曲缬沙坦类物质在制备药物成瘾和复吸药物的应用 | |
| JP7527662B2 (ja) | ピモジドとメトトレキサートの医薬組成物、及びその使用 | |
| CA2601640C (en) | Use of macrolides for treating intestinal inflammation | |
| AU2012276476B2 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| AU2345192A (en) | Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris | |
| JP5303093B2 (ja) | テナトプラゾール及びヒスタミンｈ２受容体拮抗剤を組み合わせた医薬組成物 | |
| CN115279354B (zh) | 氯胺酮用于治疗恶病质的用途 | |
| CN112512526B (zh) | 化合物a与化合物b联合在制备治疗痛风或高尿酸血症的药物中的用途 | |
| WO2024141073A1 (en) | Pharmaceutical combinations and compositions, and methods of use thereof | |
| CN114080221B (zh) | 用于减轻疼痛的布洛芬与曲马多的组合 | |
| GB2189703A (en) | Vinpocetine |